Esdy Rozali

984 total citations
8 papers, 516 citations indexed

About

Esdy Rozali is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Esdy Rozali has authored 8 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Esdy Rozali's work include Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers) and CAR-T cell therapy research (2 papers). Esdy Rozali is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers) and CAR-T cell therapy research (2 papers). Esdy Rozali collaborates with scholars based in Australia, Netherlands and Singapore. Esdy Rozali's co-authors include W. Joost Lesterhuis, Richard Lake, Bruce Robinson, Stanleyson V. Hato, Andrea Khong, Ian M. Dick, Anna K. Nowak, Karen Willard‐Gallo, Matteo Lambertini and Marco Maria Aiello and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Esdy Rozali

7 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Esdy Rozali Australia	6	374	238	134	101	40	8	516
Éléonore De Guillebon France	9	335 0.9×	184 0.8×	116 0.9×	98 1.0×	62 1.6×	13	462
Charlene M. Fares United States	5	430 1.1×	264 1.1×	106 0.8×	111 1.1×	63 1.6×	11	546
Jii Bum Lee South Korea	12	322 0.9×	171 0.7×	140 1.0×	187 1.9×	61 1.5×	47	545
Gesa Schuebbe Germany	3	239 0.6×	163 0.7×	95 0.7×	147 1.5×	54 1.4×	6	445
Sheryl Kunning United States	7	344 0.9×	305 1.3×	71 0.5×	108 1.1×	57 1.4×	10	503
Houssein Abdul Sater United States	11	373 1.0×	298 1.3×	81 0.6×	122 1.2×	41 1.0×	33	513
Talicia Savage United States	8	447 1.2×	390 1.6×	110 0.8×	68 0.7×	35 0.9×	14	617
Lillian Sun United States	7	378 1.0×	298 1.3×	63 0.5×	120 1.2×	36 0.9×	9	508
Qiu‐Xia Qu China	13	474 1.3×	466 2.0×	104 0.8×	142 1.4×	73 1.8×	33	734
Casilda Llácer Spain	7	334 0.9×	163 0.7×	77 0.6×	103 1.0×	70 1.8×	11	477

Countries citing papers authored by Esdy Rozali

Since Specialization

Citations

This map shows the geographic impact of Esdy Rozali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esdy Rozali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esdy Rozali more than expected).

Fields of papers citing papers by Esdy Rozali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esdy Rozali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esdy Rozali. The network helps show where Esdy Rozali may publish in the future.

Co-authorship network of co-authors of Esdy Rozali

This figure shows the co-authorship network connecting the top 25 collaborators of Esdy Rozali. A scholar is included among the top collaborators of Esdy Rozali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esdy Rozali. Esdy Rozali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Miranda, Mariska, et al.. (2025). ERK5 Mediates Metastatic Colonization and Remodeling of The Tumor and Tumor-Immune Microenvironment and Immunotherapy Response.

2.

Solinas, Cinzia, Marco Maria Aiello, Esdy Rozali, et al.. (2020). Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer?. Translational Oncology. 13(10). 100811–100811. 51 indexed citations

3.

Han, Shuting, Who-Whong Wang, Esdy Rozali, & Han Chong Toh. (2019). Defining precision cellular immunotherapy—seeking biomarkers to predict and optimize outcomes of T cell therapies in cancer. 2. 25–25. 1 indexed citations

4.

Saunus, Jodi M., Chanel E. Smart, Sarah Song, et al.. (2018). Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient. Breast Cancer Research and Treatment. 170(1). 179–188. 5 indexed citations

5.

Lesterhuis, W. Joost, Anya C. Jones, Esdy Rozali, et al.. (2015). Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations. Scientific Reports. 5(1). 12298–12298. 49 indexed citations

6.

Miranda, Mariska, Esdy Rozali, Kum Kum Khanna, & Fares Al‐Ejeh. (2015). MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments. Oncoscience. 2(2). 99–101. 27 indexed citations

7.

Lesterhuis, W. Joost, Anna K. Nowak, Esdy Rozali, et al.. (2013). Synergistic Effect of CTLA-4 Blockade and Cancer Chemotherapy in the Induction of Anti-Tumor Immunity. PLoS ONE. 8(4). e61895–e61895. 115 indexed citations

8.

Rozali, Esdy, Stanleyson V. Hato, Bruce Robinson, Richard Lake, & W. Joost Lesterhuis. (2012). Programmed Death Ligand 2 in Cancer-Induced Immune Suppression. SHILAP Revista de lepidopterología. 2012. 1–8. 268 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact